Virbac SA (VRBCF)
436.32
0.00 (0.00%)
USD |
OTCM |
Dec 09, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.655B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 14.78% |
| Valuation | |
| PE Ratio | 25.24 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.346 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 1.682 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 33.40% |
Profile
| Virbac SA engages in the manufacture and sale of veterinary medicines. It operates through the following business segments: Companion Animals and Farm Animals. It develops vaccines, antibiotics, anesthetics, dermatological products, and drugs for pest control, inflammation, dental care, and ophthalmological conditions of pets and livestock. It also operates through the following geographical segments: France, Europe, Latin America, North America, Asia, Pacific, and Africa and Middle-East. The Europe segment excludes France. The company was founded by Pierre-Richard Dick and Max Rombi in 1968 and is headquartered in Carros, France. |
| URL | http://www.virbac.fr |
| Investor Relations URL | N/A |
| HQ State/Province | Provence-Alpes-Cote-dAzur |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 10, 2026 (est.) |
| Last Earnings Release | Sep. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 25, 2025 |
Ratings
Profile
| Virbac SA engages in the manufacture and sale of veterinary medicines. It operates through the following business segments: Companion Animals and Farm Animals. It develops vaccines, antibiotics, anesthetics, dermatological products, and drugs for pest control, inflammation, dental care, and ophthalmological conditions of pets and livestock. It also operates through the following geographical segments: France, Europe, Latin America, North America, Asia, Pacific, and Africa and Middle-East. The Europe segment excludes France. The company was founded by Pierre-Richard Dick and Max Rombi in 1968 and is headquartered in Carros, France. |
| URL | http://www.virbac.fr |
| Investor Relations URL | N/A |
| HQ State/Province | Provence-Alpes-Cote-dAzur |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 10, 2026 (est.) |
| Last Earnings Release | Sep. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 25, 2025 |